STUDIES IN THE RAT ON THE HEMODYNAMIC OVERSHOOT RESPONSE TO WITHDRAWAL OF GUANFACINE OR CLONIDINE TREATMENT

被引:14
作者
OATES, HF
STOKER, LM
STOKES, GS
机构
[1] Cardio-Renal Unit, Medical Research Department, Sydney Hospital, Sydney
关键词
clonidine; guanfacine (BS 100‐141); withdrawal phenomena;
D O I
10.1111/j.1440-1681.1979.tb00008.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1. Normal rats were injected intramuscularly twice daily for either 3 days or 3 weeks with guanfacine (0.1 or 1.0 mg/kg), clonidine (0.01 or 0.1 mg/kg) or 0.9% saline. All were anaesthetized at various times before or after the last injection, and their arterial pressures and heart rates were monitored via a carotid artery catheter. 2. Overshoots in systolic and diastolic pressure and heart rate, reaching peak values as soon as 16 h after the last injection, occurred in all rats withdrawn from guanfacine or clonidine treatment, but in no control rats. 3. Post‐withdrawal blood pressures and heart rates of rats which had received the low dose of guanfacine or clonidine were as great as those of rats which had received the ten‐fold greater dosage. Moreover, withdrawal responses were as great in rats which had been treated for only 3 days as in those treated for 3 weeks. 4. The dosages and duration of treatments used in these experiments thus did not influence the magnitude of the haemodynamic overshoots provoked by withdrawal of guanfacine or clonidine. However, all groups of rats from which guanfacine was withheld exhibited significantly greater peak overshoots in systolic and diastolic pressure than did those withdrawn from clonidine treatment. Copyright © 1979, Wiley Blackwell. All rights reserved
引用
收藏
页码:61 / 68
页数:8
相关论文
共 9 条
[1]   THE NEUROGENIC COMPONENT IN HYPERTENSION [J].
DOYLE, AE ;
SMIRK, FH .
CIRCULATION, 1955, 12 (04) :543-552
[2]  
DUBACH UC, 1977, ARZNEIMITTELFORSCH, V27-1, P674
[3]  
GOLDBERG AD, 1976, POSTGRAD MED J, V52, P128
[4]   BLOOD-PRESSURE CRISIS FOLLOWING WITHDRAWAL OF CLONIDINE (CATAPRES, CATAPRESAN), WITH SPECIAL REFERENCE TO ARTERIAL AND URINARY CATECHOLAMINE LEVELS, AND SUGGESTIONS FOR ACUTE MANAGEMENT [J].
HANSSON, L ;
HUNYOR, SN ;
JULIUS, S ;
HOOBLER, SW .
AMERICAN HEART JOURNAL, 1973, 85 (05) :605-610
[5]   STUDIES ON CATECHOLAMINES, RENIN AND ALDOSTERONE FOLLOWING CATAPRESAN (2-(2,6-DICHLOR-PHENYLAMINE)-2-IMIDAZOLINE HYDROCHLORIDE) IN HYPERTENSIVE PATIENTS [J].
HOKFELT, B ;
HEDELAND, H ;
DYMLING, JF .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1970, 10 (03) :389-+
[6]   EFFECTS OF CLONIDINE WITHDRAWAL - POSSIBLE MECHANISMS AND SUGGESTIONS FOR MANAGEMENT [J].
HUNYOR, SN ;
HANSSON, L ;
HARRISON, TS ;
HOOBLER, SW .
BRITISH MEDICAL JOURNAL, 1973, 2 (5860) :209-211
[7]   COMPARISON OF BS 100-141 AND CLONIDINE AS ANTIHYPERTENSIVE AGENTS [J].
JAATTELA, A .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1976, 10 (01) :73-76
[8]  
SAAMELI K, 1975, CLIN EXP PHARMACOL P, P207
[9]  
SCHOLTYSIK G, 1975, ARZNEIMITTELFORSCH, V25, P1483